07/01/2025
3:27 PM | Stoke Therapeutics (Subject)
Ticho Barry (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/23/2025
3:47 PM | Skorpios Trust (Filed by)
Stoke Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
06/23/2025
3:16 PM | Hoitt Jason (Reporting)
Stoke Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/06/2025
9:03 AM | FMR LLC (Filed by)
Stoke Therapeutics (Subject)
| Form SCHEDULE 13G | |
06/04/2025
7:32 PM | Burstein Jennifer (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
7:33 PM | Harrison Seth Loring (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
7:34 PM | Krainer Adrian R. (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
7:35 PM | Menzel Garry E (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
7:36 PM | LEVIN ARTHUR A (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
7:38 PM | Smith Julie (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
7:30 PM | Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for STOK and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Stoke Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
06/04/2025
3:05 PM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2025
6:00 AM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2025
6:05 AM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2025
5:41 PM | BlackRock, Inc. (Filed by)
Stoke Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
04/15/2025
4:04 PM | BlackRock Portfolio Management LLC (Filed by)
Stoke Therapeutics (Subject)
| Form SCHEDULE 13G | |
03/20/2025
5:15 PM | Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2025
5:16 PM | LEVIN ARTHUR A (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2025
5:17 PM | Leggett Thomas (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2025
5:18 PM | Stoke Therapeutics (Issuer)
TZIANABOS ARTHUR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2025
5:19 PM | SMITH IAN F (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2025
5:05 PM | Allan Jonathan (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2025
5:12 PM | Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
3:05 PM | Stoke Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/18/2025
3:07 PM | Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
3:08 PM | Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
6:05 AM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/18/2025
3:31 PM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
8:00 AM | RTW INVESTMENTS, LP (Filed by)
Stoke Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/03/2025
3:36 PM | MORGAN STANLEY (Filed by)
Stoke Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/07/2025
6:06 AM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2025
3:14 PM | Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2024
4:23 PM | Skorpios Trust (Filed by)
Stoke Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
12/27/2024
4:13 PM | Blue Horizon Enterprise Ltd (Reporting)
Ezbon International Ltd (Reporting)
Montrago Trustees Ltd (Reporting)
Skorpios Trust (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
5:15 PM | Blue Horizon Enterprise Ltd (Reporting)
Stoke Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2024
3:05 PM | Allan Jonathan (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
3:07 PM | Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
5:59 PM | Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
| Form 4/A | |
12/10/2024
6:00 PM | Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
6:01 PM | Allan Jonathan (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
6:02 PM | Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
I was wrong about Trump (Ad) I made a mistake.
A mistake I feel very foolish about.
After speaking with Donald Trump and some of his advisors, I believed him.
I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years.
But I was wrong. Let me show you exactly what we’re doing to prepare. |
12/09/2024
3:48 PM | Allan Jonathan (Reporting)
Stoke Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2024
4:19 PM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2024
3:19 PM | Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
3:20 PM | Kaye Edward M. MD (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
3:21 PM | Allan Jonathan (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
8:00 PM | Redmile Group, LLC (Filed by)
Stoke Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
3:24 PM | BAKER BROS. ADVISORS LP (Filed by)
Stoke Therapeutics (Subject)
| Form SC 13G | |
11/14/2024
8:00 AM | Lynx1 Capital Management LP (Filed by)
Stoke Therapeutics (Subject)
| Form SC 13G/A | |
11/05/2024
3:15 PM | Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
3:05 PM | Stoke Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2024
6:05 AM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
12:56 PM | Stoke Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/01/2024
3:50 PM | Stoke Therapeutics (Subject)
Ticho Barry (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/09/2024
3:16 PM | Stoke Therapeutics (Filer)
| Form S-3ASR | |
09/23/2024
3:22 PM | Skorpios Trust (Filed by)
Stoke Therapeutics (Subject)
| Form SC 13D/A | |
09/23/2024
3:23 PM | Blue Horizon Enterprise Ltd (Reporting)
Ezbon International Ltd (Reporting)
Montrago Trustees Ltd (Reporting)
Skorpios Trust (Reporting)
Stoke Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2024
4:23 PM | Blue Horizon Enterprise Ltd (Reporting)
Stoke Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024
3:17 PM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
3:20 PM | Stoke Therapeutics (Issuer)
Ticho Barry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
6:05 AM | Stoke Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
